667 related articles for article (PubMed ID: 26755869)
1. Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma.
Wu SY; Lan SH; Liu HS
World J Gastroenterol; 2016 Jan; 22(1):176-87. PubMed ID: 26755869
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
Lamontagne J; Steel LF; Bouchard MJ
World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
[TBL] [Abstract][Full Text] [Related]
3. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
4. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
5. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
Cheong JY; Shin HD; Cho SW; Kim YJ
J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
[TBL] [Abstract][Full Text] [Related]
6. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects.
Tan YL; Chen WN
World J Gastroenterol; 2014 May; 20(20):5973-86. PubMed ID: 24876720
[TBL] [Abstract][Full Text] [Related]
8. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
9. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.
Sukowati CH; El-Khobar KE; Ie SI; Anfuso B; Muljono DH; Tiribelli C
World J Gastroenterol; 2016 Jan; 22(4):1497-512. PubMed ID: 26819517
[TBL] [Abstract][Full Text] [Related]
10. microRNAs and Hepatitis B.
Naito Y; Tanaka Y; Ochiya T
Adv Exp Med Biol; 2015; 888():389-99. PubMed ID: 26663193
[TBL] [Abstract][Full Text] [Related]
11. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
[TBL] [Abstract][Full Text] [Related]
12. The role of HBV-induced autophagy in HBV replication and HBV related-HCC.
Xie M; Yang Z; Liu Y; Zheng M
Life Sci; 2018 Jul; 205():107-112. PubMed ID: 29709654
[TBL] [Abstract][Full Text] [Related]
13. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
[TBL] [Abstract][Full Text] [Related]
14. Role of microRNAs in hepatitis B virus replication and pathogenesis.
Liu WH; Yeh SH; Chen PJ
Biochim Biophys Acta; 2011; 1809(11-12):678-85. PubMed ID: 21565290
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma and hepatitis B virus.
Chan HL; Sung JJ
Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
[TBL] [Abstract][Full Text] [Related]
16. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
[TBL] [Abstract][Full Text] [Related]
17. Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma.
Tu T; Budzinska MA; Shackel NA; Jilbert AR
Liver Int; 2015 Jul; 35(7):1786-800. PubMed ID: 25640596
[TBL] [Abstract][Full Text] [Related]
18. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
19. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
Ringelhan M; Heikenwalder M; Protzer U
Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B Virus Infection, MicroRNAs and Liver Disease.
Sarkar N; Chakravarty R
Int J Mol Sci; 2015 Aug; 16(8):17746-62. PubMed ID: 26247932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
